Envestnet Asset Management’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-1,332
| Closed | -$22K | – | 3057 |
|
|
2017
Q3 | $22K | Sell |
1,332
-1,096
| -45% | -$17.8K | ﹤0.01% | 2480 |
|
|
2017
Q2 | $43K | Buy |
2,428
+87
| +4% | +$1.63K | ﹤0.01% | 2415 |
|
|
2017
Q1 | $47K | Sell |
2,341
-60
| -2% | -$1.4K | ﹤0.01% | 2439 |
|
|
2016
Q4 | $60K | Sell |
2,401
-814
| -25% | -$19.2K | ﹤0.01% | 2383 |
|
|
2016
Q3 | $75K | Sell |
3,215
-2,863
| -47% | -$67.3K | ﹤0.01% | 2449 |
|
|
2016
Q2 | $121K | Buy |
6,078
+75
| +1% | +$1.4K | ﹤0.01% | 2346 |
|
|
2016
Q1 | $102K | Buy |
6,003
+1,898
| +46% | +$38.9K | ﹤0.01% | 2394 |
|
|
2015
Q4 | $91K | Sell |
4,105
-651
| -14% | -$13.6K | ﹤0.01% | 2413 |
|
|
2015
Q3 | $81K | Buy |
+4,756
| New | +$74K | ﹤0.01% | 2437 |
|
|
2015
Q1 | – | Sell |
-872
| Closed | -$9K | – | 2596 |
|
|
2014
Q4 | $9K | Buy |
872
+72
| +9% | +$852 | ﹤0.01% | 2010 |
|
|
2014
Q3 | $10K | Buy |
800
+257
| +47% | +$3.58K | ﹤0.01% | 2138 |
|
|
2014
Q2 | $7K | Buy |
543
+421
| +345% | +$5.5K | ﹤0.01% | 2200 |
|
|
2014
Q1 | $1K | Buy |
122
+105
| +618% | +$1.2K | ﹤0.01% | 2497 |
|
|
2013
Q4 | $0 | Buy |
+17
| New | +$199 | ﹤0.01% | 2609 |
|
Envestnet Asset Management's OME Position: Q4 2017 in Review
Envestnet Asset Management sold out of Omega Protein (OME) in Q4 2017, closing a stake of 1,332 shares — an estimated $22K sold.
Envestnet Asset Management first reported a position in OME in Q4 2013 and held it in 14 quarters. The position peaked at $121K in Q2 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Envestnet Asset Management reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Envestnet Asset Management sold 1,332 Omega Protein shares in Q4 2017, an estimated $22K.
- Envestnet Asset Management first reported a position in Omega Protein in Q4 2013 and held it in 14 quarters.
- Envestnet Asset Management's Omega Protein position peaked at $121K in Q2 2016.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Envestnet Asset Management's 13F filing for Q4 2017, filed 20 Feb 2018.